How big is the musculoskeletal disorders therapeutics market?

The global Musculoskeletal Disorders Therapeutics market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.

Fully considering the economic change by this health crisis, Biologics accounting for % of the Musculoskeletal Disorders Therapeutics global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period.

While Osteoarthritis segment is altered to an % CAGR throughout this forecast period.

China Musculoskeletal Disorders Therapeutics market size is valued at US$ million in 2021, while the North America and Europe Musculoskeletal Disorders Therapeutics are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period.

As for the Europe Musculoskeletal Disorders Therapeutics landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Musculoskeletal Disorders Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Musculoskeletal Disorders Therapeutics market in terms of revenue.

Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Musculoskeletal Disorders Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Musculoskeletal Disorders Therapeutics market.

Global Musculoskeletal Disorders Therapeutics Scope and Market Size

Musculoskeletal Disorders Therapeutics market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Musculoskeletal Disorders Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

Biologics

Small Molecules

Segment by Application

Osteoarthritis

Osteoporosis

Psoriatic Arthritis

Ankylosing Spondylitis

Fibromyalgia

BY COMPANY

AbbVie

Johnson & Johnson

Amgen

Pfizer

F. Hoffmann-La Roche

Eli Lilly

Merck

Novartis

AstraZeneca

Astellas

AB Sciences

3SBio

Samsung Bioepis

Sanofi

Taisho Pharmaceutical

Takeda

Zosano Pharma

LG Life Sciences

BY REGION

North America

United States

Canada

Europe

Germany

France

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

FEATURED COMPANIES

Taisho Pharmaceutical

Takeda

Zosano Pharma

LG Life Sciences

1 Report Business Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Musculoskeletal Disorders Therapeutics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028

1.2.2 Biologics

1.2.3 Small Molecules

1.3 Market by Application

1.3.1 Global Musculoskeletal Disorders Therapeutics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028

1.3.2 Osteoarthritis

1.3.3 Osteoporosis

1.3.4 Psoriatic Arthritis

1.3.5 Ankylosing Spondylitis

1.3.6 Fibromyalgia

1.4 Study Objectives

1.5 Years Considered

2 Global Growth Trends

2.1 Global Musculoskeletal Disorders Therapeutics Market Perspective (2017-2028)

2.2 Musculoskeletal Disorders Therapeutics Growth Trends by Region

2.2.1 Musculoskeletal Disorders Therapeutics Market Size by Region: 2017 VS 2021 VS 2028

2.2.2 Musculoskeletal Disorders Therapeutics Historic Market Size by Region (2017-2022)

2.2.3 Musculoskeletal Disorders Therapeutics Forecasted Market Size by Region (2023-2028)

2.3 Musculoskeletal Disorders Therapeutics Market Dynamics

2.3.1 Musculoskeletal Disorders Therapeutics Industry Trends

2.3.2 Musculoskeletal Disorders Therapeutics Market Drivers

2.3.3 Musculoskeletal Disorders Therapeutics Market Challenges

2.3.4 Musculoskeletal Disorders Therapeutics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Musculoskeletal Disorders Therapeutics Players by Revenue

3.1.1 Global Top Musculoskeletal Disorders Therapeutics Players by Revenue (2017-2022)

3.1.2 Global Musculoskeletal Disorders Therapeutics Revenue Market Share by Players (2017-2022)

3.2 Global Musculoskeletal Disorders Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Musculoskeletal Disorders Therapeutics Revenue

3.4 Global Musculoskeletal Disorders Therapeutics Market Concentration Ratio

3.4.1 Global Musculoskeletal Disorders Therapeutics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Musculoskeletal Disorders Therapeutics Revenue in 2021

3.5 Musculoskeletal Disorders Therapeutics Key Players Head office and Area Served

3.6 Key Players Musculoskeletal Disorders Therapeutics Product Solution and Service

3.7 Date of Enter into Musculoskeletal Disorders Therapeutics Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Musculoskeletal Disorders Therapeutics Breakdown Data by Type

4.1 Global Musculoskeletal Disorders Therapeutics Historic Market Size by Type (2017-2022)

4.2 Global Musculoskeletal Disorders Therapeutics Forecasted Market Size by Type (2023-2028)

5 Musculoskeletal Disorders Therapeutics Breakdown Data by Application

5.1 Global Musculoskeletal Disorders Therapeutics Historic Market Size by Application (2017-2022)

5.2 Global Musculoskeletal Disorders Therapeutics Forecasted Market Size by Application (2023-2028)

6 North America

6.1 North America Musculoskeletal Disorders Therapeutics Market Size (2017-2028)

6.2 North America Musculoskeletal Disorders Therapeutics Market Size by Type

6.2.1 North America Musculoskeletal Disorders Therapeutics Market Size by Type (2017-2022)

6.2.2 North America Musculoskeletal Disorders Therapeutics Market Size by Type (2023-2028)

6.2.3 North America Musculoskeletal Disorders Therapeutics Market Share by Type (2017-2028)

6.3 North America Musculoskeletal Disorders Therapeutics Market Size by Application

6.3.1 North America Musculoskeletal Disorders Therapeutics Market Size by Application (2017-2022)

6.3.2 North America Musculoskeletal Disorders Therapeutics Market Size by Application (2023-2028)

6.3.3 North America Musculoskeletal Disorders Therapeutics Market Share by Application (2017-2028)

6.4 North America Musculoskeletal Disorders Therapeutics Market Size by Country

6.4.1 North America Musculoskeletal Disorders Therapeutics Market Size by Country (2017-2022)

6.4.2 North America Musculoskeletal Disorders Therapeutics Market Size by Country (2023-2028)

6.4.3 U.S.

6.4.4 Canada

7 Europe

7.1 Europe Musculoskeletal Disorders Therapeutics Market Size (2017-2028)

7.2 Europe Musculoskeletal Disorders Therapeutics Market Size by Type

7.2.1 Europe Musculoskeletal Disorders Therapeutics Market Size by Type (2017-2022)

7.2.2 Europe Musculoskeletal Disorders Therapeutics Market Size by Type (2023-2028)

7.2.3 Europe Musculoskeletal Disorders Therapeutics Market Share by Type (2017-2028)

7.3 Europe Musculoskeletal Disorders Therapeutics Market Size by Application

7.3.1 Europe Musculoskeletal Disorders Therapeutics Market Size by Application (2017-2022)

7.3.2 Europe Musculoskeletal Disorders Therapeutics Market Size by Application (2023-2028)

7.3.3 Europe Musculoskeletal Disorders Therapeutics Market Share by Application (2017-2028)

7.4 Europe Musculoskeletal Disorders Therapeutics Market Size by Country

7.4.1 Europe Musculoskeletal Disorders Therapeutics Market Size by Country (2017-2022)

7.4.2 Europe Musculoskeletal Disorders Therapeutics Market Size by Country (2023-2028)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Musculoskeletal Disorders Therapeutics Market Size (2017-2028)

8.2 Asia-Pacific Musculoskeletal Disorders Therapeutics Market Size by Type

8.2.1 Asia-Pacific Musculoskeletal Disorders Therapeutics Market Size by Type (2017-2022)

8.2.2 Asia-Pacific Musculoskeletal Disorders Therapeutics Market Size by Type (2023-2028)

8.2.3 Asia-Pacific Musculoskeletal Disorders Therapeutics Market Share by Type (2017-2028)

8.3 Asia-Pacific Musculoskeletal Disorders Therapeutics Market Size by Application

8.3.1 Asia-Pacific Musculoskeletal Disorders Therapeutics Market Size by Application (2017-2022)

8.3.2 Asia-Pacific Musculoskeletal Disorders Therapeutics Market Size by Application (2023-2028)

8.3.3 Asia-Pacific Musculoskeletal Disorders Therapeutics Market Share by Application (2017-2028)

8.4 Asia-Pacific Musculoskeletal Disorders Therapeutics Market Size by Region

8.4.1 Asia-Pacific Musculoskeletal Disorders Therapeutics Market Size by Region (2017-2022)

8.4.2 Asia-Pacific Musculoskeletal Disorders Therapeutics Market Size by Region (2023-2028)

8.4.3 China

8.4.4 Japan

8.4.5 South Korea

8.4.6 Southeast Asia

8.4.7 India

8.4.8 Australia

9 Latin America

9.1 Latin America Musculoskeletal Disorders Therapeutics Market Size (2017-2028)

9.2 Latin America Musculoskeletal Disorders Therapeutics Market Size by Type

9.2.1 Latin America Musculoskeletal Disorders Therapeutics Market Size by Type (2017-2022)

9.2.2 Latin America Musculoskeletal Disorders Therapeutics Market Size by Type (2023-2028)

9.2.3 Latin America Musculoskeletal Disorders Therapeutics Market Share by Type (2017-2028)

9.3 Latin America Musculoskeletal Disorders Therapeutics Market Size by Application

9.3.1 Latin America Musculoskeletal Disorders Therapeutics Market Size by Application (2017-2022)

9.3.2 Latin America Musculoskeletal Disorders Therapeutics Market Size by Application (2023-2028)

9.3.3 Latin America Musculoskeletal Disorders Therapeutics Market Share by Application (2017-2028)

9.4 Latin America Musculoskeletal Disorders Therapeutics Market Size by Country

9.4.1 Latin America Musculoskeletal Disorders Therapeutics Market Size by Country (2017-2022)

9.4.2 Latin America Musculoskeletal Disorders Therapeutics Market Size by Country (2023-2028)

9.4.3 Mexico

9.4.4 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Musculoskeletal Disorders Therapeutics Market Size (2017-2028)

10.2 Middle East & Africa Musculoskeletal Disorders Therapeutics Market Size by Type

10.2.1 Middle East & Africa Musculoskeletal Disorders Therapeutics Market Size by Type (2017-2022)

10.2.2 Middle East & Africa Musculoskeletal Disorders Therapeutics Market Size by Type (2023-2028)

10.2.3 Middle East & Africa Musculoskeletal Disorders Therapeutics Market Share by Type (2017-2028)

10.3 Middle East & Africa Musculoskeletal Disorders Therapeutics Market Size by Application

10.3.1 Middle East & Africa Musculoskeletal Disorders Therapeutics Market Size by Application (2017-2022)

10.3.2 Middle East & Africa Musculoskeletal Disorders Therapeutics Market Size by Application (2023-2028)

10.3.3 Middle East & Africa Musculoskeletal Disorders Therapeutics Market Share by Application (2017-2028)

10.4 Middle East & Africa Musculoskeletal Disorders Therapeutics Market Size by Country

10.4.1 Middle East & Africa Musculoskeletal Disorders Therapeutics Market Size by Country (2017-2022)

10.4.2 Middle East & Africa Musculoskeletal Disorders Therapeutics Market Size by Country (2023-2028)

10.4.3 Turkey

10.4.4 Saudi Arabia

10.4.5 UAE

11 Key Players Profiles

11.1 AbbVie

11.1.1 AbbVie Company Details

11.1.2 AbbVie Business Overview

11.1.3 AbbVie Musculoskeletal Disorders Therapeutics Introduction

11.1.4 AbbVie Revenue in Musculoskeletal Disorders Therapeutics Business (2017-2022)

11.1.5 AbbVie Recent Developments

11.2 Johnson & Johnson

11.2.1 Johnson & Johnson Company Details

11.2.2 Johnson & Johnson Business Overview

11.2.3 Johnson & Johnson Musculoskeletal Disorders Therapeutics Introduction

11.2.4 Johnson & Johnson Revenue in Musculoskeletal Disorders Therapeutics Business (2017-2022)

11.2.5 Johnson & Johnson Recent Developments

11.3 Amgen

11.3.1 Amgen Company Details

11.3.2 Amgen Business Overview

11.3.3 Amgen Musculoskeletal Disorders Therapeutics Introduction

11.3.4 Amgen Revenue in Musculoskeletal Disorders Therapeutics Business (2017-2022)

11.3.5 Amgen Recent Developments

11.4 Pfizer

11.4.1 Pfizer Company Details

11.4.2 Pfizer Business Overview

11.4.3 Pfizer Musculoskeletal Disorders Therapeutics Introduction

11.4.4 Pfizer Revenue in Musculoskeletal Disorders Therapeutics Business (2017-2022)

11.4.5 Pfizer Recent Developments

11.5 F. Hoffmann-La Roche

11.5.1 F. Hoffmann-La Roche Company Details

11.5.2 F. Hoffmann-La Roche Business Overview

11.5.3 F. Hoffmann-La Roche Musculoskeletal Disorders Therapeutics Introduction

11.5.4 F. Hoffmann-La Roche Revenue in Musculoskeletal Disorders Therapeutics Business (2017-2022)

11.5.5 F. Hoffmann-La Roche Recent Developments

11.6 Eli Lilly

11.6.1 Eli Lilly Company Details

11.6.2 Eli Lilly Business Overview

11.6.3 Eli Lilly Musculoskeletal Disorders Therapeutics Introduction

11.6.4 Eli Lilly Revenue in Musculoskeletal Disorders Therapeutics Business (2017-2022)

11.6.5 Eli Lilly Recent Developments

11.7 Merck

11.7.1 Merck Company Details

11.7.2 Merck Business Overview

11.7.3 Merck Musculoskeletal Disorders Therapeutics Introduction

11.7.4 Merck Revenue in Musculoskeletal Disorders Therapeutics Business (2017-2022)

11.7.5 Merck Recent Developments

11.8 Novartis

11.8.1 Novartis Company Details

11.8.2 Novartis Business Overview

11.8.3 Novartis Musculoskeletal Disorders Therapeutics Introduction

11.8.4 Novartis Revenue in Musculoskeletal Disorders Therapeutics Business (2017-2022)

11.8.5 Novartis Recent Developments

11.9 AstraZeneca

11.9.1 AstraZeneca Company Details

11.9.2 AstraZeneca Business Overview

11.9.3 AstraZeneca Musculoskeletal Disorders Therapeutics Introduction

11.9.4 AstraZeneca Revenue in Musculoskeletal Disorders Therapeutics Business (2017-2022)

11.9.5 AstraZeneca Recent Developments

11.10 Astellas

11.10.1 Astellas Company Details

11.10.2 Astellas Business Overview

11.10.3 Astellas Musculoskeletal Disorders Therapeutics Introduction

11.10.4 Astellas Revenue in Musculoskeletal Disorders Therapeutics Business (2017-2022)

11.10.5 Astellas Recent Developments

11.11 AB Sciences

11.11.1 AB Sciences Company Details

11.11.2 AB Sciences Business Overview

11.11.3 AB Sciences Musculoskeletal Disorders Therapeutics Introduction

11.11.4 AB Sciences Revenue in Musculoskeletal Disorders Therapeutics Business (2017-2022)

11.11.5 AB Sciences Recent Developments

11.12 3SBio

11.12.1 3SBio Company Details

11.12.2 3SBio Business Overview

11.12.3 3SBio Musculoskeletal Disorders Therapeutics Introduction

11.12.4 3SBio Revenue in Musculoskeletal Disorders Therapeutics Business (2017-2022)

11.12.5 3SBio Recent Developments

11.13 Samsung Bioepis

11.13.1 Samsung Bioepis Company Details

11.13.2 Samsung Bioepis Business Overview

11.13.3 Samsung Bioepis Musculoskeletal Disorders Therapeutics Introduction

11.13.4 Samsung Bioepis Revenue in Musculoskeletal Disorders Therapeutics Business (2017-2022)

11.13.5 Samsung Bioepis Recent Developments

11.14 Sanofi

11.14.1 Sanofi Company Details

11.14.2 Sanofi Business Overview

11.14.3 Sanofi Musculoskeletal Disorders Therapeutics Introduction

11.14.4 Sanofi Revenue in Musculoskeletal Disorders Therapeutics Business (2017-2022)

11.14.5 Sanofi Recent Developments

11.15 Taisho Pharmaceutical

11.15.1 Taisho Pharmaceutical Company Details

11.15.2 Taisho Pharmaceutical Business Overview

11.15.3 Taisho Pharmaceutical Musculoskeletal Disorders Therapeutics Introduction

11.15.4 Taisho Pharmaceutical Revenue in Musculoskeletal Disorders Therapeutics Business (2017-2022)

11.15.5 Taisho Pharmaceutical Recent Developments

11.16 Takeda

11.16.1 Takeda Company Details

11.16.2 Takeda Business Overview

11.16.3 Takeda Musculoskeletal Disorders Therapeutics Introduction

11.16.4 Takeda Revenue in Musculoskeletal Disorders Therapeutics Business (2017-2022)

11.16.5 Takeda Recent Developments

11.17 Zosano Pharma

11.17.1 Zosano Pharma Company Details

11.17.2 Zosano Pharma Business Overview

11.17.3 Zosano Pharma Musculoskeletal Disorders Therapeutics Introduction

11.17.4 Zosano Pharma Revenue in Musculoskeletal Disorders Therapeutics Business (2017-2022)

11.17.5 Zosano Pharma Recent Developments

11.18 LG Life Sciences

11.18.1 LG Life Sciences Company Details

11.18.2 LG Life Sciences Business Overview

11.18.3 LG Life Sciences Musculoskeletal Disorders Therapeutics Introduction

11.18.4 LG Life Sciences Revenue in Musculoskeletal Disorders Therapeutics Business (2017-2022)

11.18.5 LG Life Sciences Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Taisho Pharmaceutical

Takeda

Zosano Pharma

LG Life Sciences

List of Tables

Table 1. Global Musculoskeletal Disorders Therapeutics Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028

Table 2. Key Players of Biologics

Table 3. Key Players of Small Molecules

Table 4. Global Musculoskeletal Disorders Therapeutics Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028

Table 5. Global Musculoskeletal Disorders Therapeutics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028

Table 6. Global Musculoskeletal Disorders Therapeutics Market Size by Region (2017-2022) & (US$ Million)

Table 7. Global Musculoskeletal Disorders Therapeutics Market Share by Region (2017-2022)

Table 8. Global Musculoskeletal Disorders Therapeutics Forecasted Market Size by Region (2023-2028) & (US$ Million)

Table 9. Global Musculoskeletal Disorders Therapeutics Market Share by Region (2023-2028)

Table 10. Musculoskeletal Disorders Therapeutics Market Trends

Table 11. Musculoskeletal Disorders Therapeutics Market Drivers

Table 12. Musculoskeletal Disorders Therapeutics Market Challenges

Table 13. Musculoskeletal Disorders Therapeutics Market Restraints

Table 14. Global Musculoskeletal Disorders Therapeutics Revenue by Players (2017-2022) & (US$ Million)

Table 15. Global Musculoskeletal Disorders Therapeutics Revenue Share by Players (2017-2022)

Table 16. Global Top Musculoskeletal Disorders Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Musculoskeletal Disorders Therapeutics as of 2021)

Table 17. Ranking of Global Top Musculoskeletal Disorders Therapeutics Companies by Revenue (US$ Million) in 2021

Table 18. Global 5 Largest Players Market Share by Musculoskeletal Disorders Therapeutics Revenue (CR5 and HHI) & (2017-2022)

Table 19. Key Players Headquarters and Area Served

Table 20. Key Players Musculoskeletal Disorders Therapeutics Product Solution and Service

Table 21. Date of Enter into Musculoskeletal Disorders Therapeutics Market

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Musculoskeletal Disorders Therapeutics Market Size by Type (2017-2022) & (US$ Million)

Table 24. Global Musculoskeletal Disorders Therapeutics Revenue Market Share by Type (2017-2022)

Table 25. Global Musculoskeletal Disorders Therapeutics Forecasted Market Size by Type (2023-2028) & (US$ Million)

Table 26. Global Musculoskeletal Disorders Therapeutics Revenue Market Share by Type (2023-2028)

Table 27. Global Musculoskeletal Disorders Therapeutics Market Size by Application (2017-2022) & (US$ Million)

Table 28. Global Musculoskeletal Disorders Therapeutics Revenue Share by Application (2017-2022)

Table 29. Global Musculoskeletal Disorders Therapeutics Forecasted Market Size by Application (2023-2028) & (US$ Million)

Table 30. Global Musculoskeletal Disorders Therapeutics Revenue Share by Application (2023-2028)

Table 31. North America Musculoskeletal Disorders Therapeutics Market Size by Type (2017-2022) & (US$ Million)

Table 32. North America Musculoskeletal Disorders Therapeutics Market Size by Type (2023-2028) & (US$ Million)

Table 33. North America Musculoskeletal Disorders Therapeutics Market Size by Application (2017-2022) & (US$ Million)

Table 34. North America Musculoskeletal Disorders Therapeutics Market Size by Application (2023-2028) & (US$ Million)

Table 35. North America Musculoskeletal Disorders Therapeutics Market Size by Country (2017-2022) & (US$ Million)

Table 36. North America Musculoskeletal Disorders Therapeutics Market Size by Country (2023-2028) & (US$ Million)

Table 37. Europe Musculoskeletal Disorders Therapeutics Market Size by Type (2017-2022) & (US$ Million)

Table 38. Europe Musculoskeletal Disorders Therapeutics Market Size by Type (2023-2028) & (US$ Million)

Table 39. Europe Musculoskeletal Disorders Therapeutics Market Size by Application (2017-2022) & (US$ Million)

Table 40. Europe Musculoskeletal Disorders Therapeutics Market Size by Application (2023-2028) & (US$ Million)

Table 41. Europe Musculoskeletal Disorders Therapeutics Market Size by Country (2017-2022) & (US$ Million)

Table 42. Europe Musculoskeletal Disorders Therapeutics Market Size by Country (2023-2028) & (US$ Million)

Table 43. Asia Pacific Musculoskeletal Disorders Therapeutics Market Size by Type (2017-2022) & (US$ Million)

Table 44. Asia Pacific Musculoskeletal Disorders Therapeutics Market Size by Type (2023-2028) & (US$ Million)

Table 45. Asia Pacific Musculoskeletal Disorders Therapeutics Market Size by Application (2017-2022) & (US$ Million)

Table 46. Asia Pacific Musculoskeletal Disorders Therapeutics Market Size by Application (2023-2028) & (US$ Million)

Table 47. Asia Pacific Musculoskeletal Disorders Therapeutics Market Size by Region (2017-2022) & (US$ Million)

Table 48. Asia Pacific Musculoskeletal Disorders Therapeutics Market Size by Region (2023-2028) & (US$ Million)

Table 49. Latin America Musculoskeletal Disorders Therapeutics Market Size by Type (2017-2022) & (US$ Million)

Table 50. Latin America Musculoskeletal Disorders Therapeutics Market Size by Type (2023-2028) & (US$ Million)

Table 51. Latin America Musculoskeletal Disorders Therapeutics Market Size by Application (2017-2022) & (US$ Million)

Table 52. Latin America Musculoskeletal Disorders Therapeutics Market Size by Application (2023-2028) & (US$ Million)

Table 53. Latin America Musculoskeletal Disorders Therapeutics Market Size by Country (2017-2022) & (US$ Million)

Table 54. Latin America Musculoskeletal Disorders Therapeutics Market Size by Country (2023-2028) & (US$ Million)

Table 55. Middle East and Africa Musculoskeletal Disorders Therapeutics Market Size by Type (2017-2022) & (US$ Million)

Table 56. Middle East and Africa Musculoskeletal Disorders Therapeutics Market Size by Type (2023-2028) & (US$ Million)

Table 57. Middle East and Africa Musculoskeletal Disorders Therapeutics Market Size by Application (2017-2022) & (US$ Million)

Table 58. Middle East and Africa Musculoskeletal Disorders Therapeutics Market Size by Application (2023-2028) & (US$ Million)

Table 59. Middle East and Africa Musculoskeletal Disorders Therapeutics Market Size by Country (2017-2022) & (US$ Million)

Table 60. Middle East and Africa Musculoskeletal Disorders Therapeutics Market Size by Country (2023-2028) & (US$ Million)

Table 61. AbbVie Company Details

Table 62. AbbVie Business Overview

Table 63. AbbVie Musculoskeletal Disorders Therapeutics Product

Table 64. AbbVie Revenue in Musculoskeletal Disorders Therapeutics Business (2017-2022) & (US$ Million)

Table 65. AbbVie Recent Developments

Table 66. Johnson & Johnson Company Details

Table 67. Johnson & Johnson Business Overview

Table 68. Johnson & Johnson Musculoskeletal Disorders Therapeutics Product

Table 69. Johnson & Johnson Revenue in Musculoskeletal Disorders Therapeutics Business (2017-2022) & (US$ Million)

Table 70. Johnson & Johnson Recent Developments

Table 71. Amgen Company Details

Table 72. Amgen Business Overview

Table 73. Amgen Musculoskeletal Disorders Therapeutics Product

Table 74. Amgen Revenue in Musculoskeletal Disorders Therapeutics Business (2017-2022) & (US$ Million)

Table 75. Amgen Recent Developments

Table 76. Pfizer Company Details

Table 77. Pfizer Business Overview

Table 78. Pfizer Musculoskeletal Disorders Therapeutics Product

Table 79. Pfizer Revenue in Musculoskeletal Disorders Therapeutics Business (2017-2022) & (US$ Million)

Table 80. Pfizer Recent Developments

Table 81. F. Hoffmann-La Roche Company Details

Table 82. F. Hoffmann-La Roche Business Overview

Table 83. F. Hoffmann-La Roche Musculoskeletal Disorders Therapeutics Product

Table 84. F. Hoffmann-La Roche Revenue in Musculoskeletal Disorders Therapeutics Business (2017-2022) & (US$ Million)

Table 85. F. Hoffmann-La Roche Recent Developments

Table 86. Eli Lilly Company Details

Table 87. Eli Lilly Business Overview

Table 88. Eli Lilly Musculoskeletal Disorders Therapeutics Product

Table 89. Eli Lilly Revenue in Musculoskeletal Disorders Therapeutics Business (2017-2022) & (US$ Million)

Table 90. Eli Lilly Recent Developments

Table 91. Merck Company Details

Table 92. Merck Business Overview

Table 93. Merck Musculoskeletal Disorders Therapeutics Product

Table 94. Merck Revenue in Musculoskeletal Disorders Therapeutics Business (2017-2022) & (US$ Million)

Table 95. Merck Recent Developments

Table 96. Novartis Company Details

Table 97. Novartis Business Overview

Table 98. Novartis Musculoskeletal Disorders Therapeutics Product

Table 99. Novartis Revenue in Musculoskeletal Disorders Therapeutics Business (2017-2022) & (US$ Million)

Table 100. Novartis Recent Developments

Table 101. AstraZeneca Company Details

Table 102. AstraZeneca Business Overview

Table 103. AstraZeneca Musculoskeletal Disorders Therapeutics Product

Table 104. AstraZeneca Revenue in Musculoskeletal Disorders Therapeutics Business (2017-2022) & (US$ Million)

Table 105. AstraZeneca Recent Developments

Table 106. Astellas Company Details

Table 107. Astellas Business Overview

Table 108. Astellas Musculoskeletal Disorders Therapeutics Product

Table 109. Astellas Revenue in Musculoskeletal Disorders Therapeutics Business (2017-2022) & (US$ Million)

Table 110. Astellas Recent Developments

Table 111. AB Sciences Company Details

Table 112. AB Sciences Business Overview

Table 113. AB Sciences Musculoskeletal Disorders Therapeutics Product

Table 114. AB Sciences Revenue in Musculoskeletal Disorders Therapeutics Business (2017-2022) & (US$ Million)

Table 115. AB Sciences Recent Developments

Table 116. 3SBio Company Details

Table 117. 3SBio Business Overview

Table 118. 3SBio Musculoskeletal Disorders Therapeutics Product

Table 119. 3SBio Revenue in Musculoskeletal Disorders Therapeutics Business (2017-2022) & (US$ Million)

Table 120. 3SBio Recent Developments

Table 121. Samsung Bioepis Company Details

Table 122. Samsung Bioepis Business Overview

Table 123. Samsung Bioepis Musculoskeletal Disorders Therapeutics Product

Table 124. Samsung Bioepis Revenue in Musculoskeletal Disorders Therapeutics Business (2017-2022) & (US$ Million)

Table 125. Samsung Bioepis Recent Developments

Table 126. Sanofi Company Details

Table 127. Sanofi Business Overview

Table 128. Sanofi Musculoskeletal Disorders Therapeutics Product

Table 129. Sanofi Revenue in Musculoskeletal Disorders Therapeutics Business (2017-2022) & (US$ Million)

Table 130. Sanofi Recent Developments

Table 131. Taisho Pharmaceutical Company Details

Table 132. Taisho Pharmaceutical Business Overview

Table 133. Taisho Pharmaceutical Musculoskeletal Disorders Therapeutics Product

Table 134. Taisho Pharmaceutical Revenue in Musculoskeletal Disorders Therapeutics Business (2017-2022) & (US$ Million)

Table 135. Taisho Pharmaceutical Recent Developments

Table 136. Takeda Company Details

Table 137. Takeda Business Overview

Table 138. Takeda Musculoskeletal Disorders Therapeutics Product

Table 139. Takeda Revenue in Musculoskeletal Disorders Therapeutics Business (2017-2022) & (US$ Million)

Table 140. Takeda Recent Developments

Table 141. Zosano Pharma Company Details

Table 142. Zosano Pharma Business Overview

Table 143. Zosano Pharma Musculoskeletal Disorders Therapeutics Product

Table 144. Zosano Pharma Revenue in Musculoskeletal Disorders Therapeutics Business (2017-2022) & (US$ Million)

Table 145. Zosano Pharma Recent Developments

Table 146. LG Life Sciences Company Details

Table 147. LG Life Sciences Business Overview

Table 148. LG Life Sciences Musculoskeletal Disorders Therapeutics Product

Table 149. LG Life Sciences Revenue in Musculoskeletal Disorders Therapeutics Business (2017-2022) & (US$ Million)

Table 150. LG Life Sciences Recent Developments

Table 151. Research Programs/Design for This Report

Table 152. Key Data Information from Secondary Sources

Table 153. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Musculoskeletal Disorders Therapeutics Market Share by Type: 2021 VS 2028

Figure 2. Biologics Features

Figure 3. Small Molecules Features

Figure 4. Global Musculoskeletal Disorders Therapeutics Market Share by Application: 2021 VS 2028

Figure 5. Osteoarthritis Case Studies

Figure 6. Osteoporosis Case Studies

Figure 7. Psoriatic Arthritis Case Studies

Figure 8. Ankylosing Spondylitis Case Studies

Figure 9. Fibromyalgia Case Studies

Figure 10. Musculoskeletal Disorders Therapeutics Report Years Considered

Figure 11. Global Musculoskeletal Disorders Therapeutics Market Size (US$ Million), Year-over-Year: 2017-2028

Figure 12. Global Musculoskeletal Disorders Therapeutics Market Size, (US$ Million), 2017 VS 2021 VS 2028

Figure 13. Global Musculoskeletal Disorders Therapeutics Market Share by Region: 2021 VS 2028

Figure 14. Global Musculoskeletal Disorders Therapeutics Market Share by Players in 2021

Figure 15. Global Top Musculoskeletal Disorders Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Musculoskeletal Disorders Therapeutics as of 2021)

Figure 16. The Top 10 and 5 Players Market Share by Musculoskeletal Disorders Therapeutics Revenue in 2021

Figure 17. North America Musculoskeletal Disorders Therapeutics Market Size YoY (2017-2028) & (US$ Million)

Figure 18. North America Musculoskeletal Disorders Therapeutics Market Size Market Share by Type (2017-2028)

Figure 19. North America Musculoskeletal Disorders Therapeutics Market Size Market Share by Application (2017-2028)

Figure 20. North America Musculoskeletal Disorders Therapeutics Market Size Share by Country (2017-2028)

Figure 21. United States Musculoskeletal Disorders Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 22. Canada Musculoskeletal Disorders Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 23. Europe Musculoskeletal Disorders Therapeutics Market Size YoY (2017-2028) & (US$ Million)

Figure 24. Europe Musculoskeletal Disorders Therapeutics Market Size Market Share by Type (2017-2028)

Figure 25. Europe Musculoskeletal Disorders Therapeutics Market Size Market Share by Application (2017-2028)

Figure 26. Europe Musculoskeletal Disorders Therapeutics Market Size Share by Country (2017-2028)

Figure 27. Germany Musculoskeletal Disorders Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 28. France Musculoskeletal Disorders Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 29. U.K. Musculoskeletal Disorders Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 30. Italy Musculoskeletal Disorders Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 31. Russia Musculoskeletal Disorders Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 32. Nordic Countries Musculoskeletal Disorders Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 33. Asia-Pacific Musculoskeletal Disorders Therapeutics Market Size YoY (2017-2028) & (US$ Million)

Figure 34. Asia Pacific Musculoskeletal Disorders Therapeutics Market Size Market Share by Type (2017-2028)

Figure 35. Asia Pacific Musculoskeletal Disorders Therapeutics Market Size Market Share by Application (2017-2028)

Figure 36. Asia Pacific Musculoskeletal Disorders Therapeutics Market Size Share by Region (2017-2028)

Figure 37. China Musculoskeletal Disorders Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 38. Japan Musculoskeletal Disorders Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 39. South Korea Musculoskeletal Disorders Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 40. Southeast Asia Musculoskeletal Disorders Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 41. India Musculoskeletal Disorders Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 42. Australia Musculoskeletal Disorders Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

List of Figures

Figure 43. Latin America Musculoskeletal Disorders Therapeutics Market Size YoY (2017-2028) & (US$ Million)

Figure 44. Latin America Musculoskeletal Disorders Therapeutics Market Size Market Share by Type (2017-2028)

Figure 45. Latin America Musculoskeletal Disorders Therapeutics Market Size Market Share by Application (2017-2028)

Figure 46. Latin America Musculoskeletal Disorders Therapeutics Market Size Share by Country (2017-2028)

Figure 47. Mexico Musculoskeletal Disorders Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 48. Brazil Musculoskeletal Disorders Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 49. Middle East & Africa Musculoskeletal Disorders Therapeutics Market Size YoY (2017-2028) & (US$ Million)

Figure 50. Middle East and Africa Musculoskeletal Disorders Therapeutics Market Size Market Share by Type (2017-2028)

Figure 51. Middle East and Africa Musculoskeletal Disorders Therapeutics Market Size Market Share by Application (2017-2028)

Figure 52. Middle East and Africa Musculoskeletal Disorders Therapeutics Market Size Share by Country (2017-2028)

Figure 53. Turkey Musculoskeletal Disorders Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 54. Saudi Arabia Musculoskeletal Disorders Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 55. UAE Musculoskeletal Disorders Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 56. AbbVie Revenue Growth Rate in Musculoskeletal Disorders Therapeutics Business (2017-2022)

Figure 57. Johnson & Johnson Revenue Growth Rate in Musculoskeletal Disorders Therapeutics Business (2017-2022)

Figure 58. Amgen Revenue Growth Rate in Musculoskeletal Disorders Therapeutics Business (2017-2022)

Figure 59. Pfizer Revenue Growth Rate in Musculoskeletal Disorders Therapeutics Business (2017-2022)

Figure 60. F. Hoffmann-La Roche Revenue Growth Rate in Musculoskeletal Disorders Therapeutics Business (2017-2022)

Figure 61. Eli Lilly Revenue Growth Rate in Musculoskeletal Disorders Therapeutics Business (2017-2022)

Figure 62. Merck Revenue Growth Rate in Musculoskeletal Disorders Therapeutics Business (2017-2022)

Figure 63. Novartis Revenue Growth Rate in Musculoskeletal Disorders Therapeutics Business (2017-2022)

Figure 64. AstraZeneca Revenue Growth Rate in Musculoskeletal Disorders Therapeutics Business (2017-2022)

Figure 65. Astellas Revenue Growth Rate in Musculoskeletal Disorders Therapeutics Business (2017-2022)

Figure 66. AB Sciences Revenue Growth Rate in Musculoskeletal Disorders Therapeutics Business (2017-2022)

Figure 67. 3SBio Revenue Growth Rate in Musculoskeletal Disorders Therapeutics Business (2017-2022)

Figure 68. Samsung Bioepis Revenue Growth Rate in Musculoskeletal Disorders Therapeutics Business (2017-2022)

Figure 69. Sanofi Revenue Growth Rate in Musculoskeletal Disorders Therapeutics Business (2017-2022)

Figure 70. Taisho Pharmaceutical Revenue Growth Rate in Musculoskeletal Disorders Therapeutics Business (2017-2022)

Figure 71. Takeda Revenue Growth Rate in Musculoskeletal Disorders Therapeutics Business (2017-2022)

Figure 72. Zosano Pharma Revenue Growth Rate in Musculoskeletal Disorders Therapeutics Business (2017-2022)

Figure 73. LG Life Sciences Revenue Growth Rate in Musculoskeletal Disorders Therapeutics Business (2017-2022)

Figure 74. Bottom-up and Top-down Approaches for This Report

Figure 75. Data Triangulation

Figure 76. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (10% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Musculoskeletal Disorders Therapeutics Market Insights, Forecast to 2028

Published Date: February 2022

Report Code: QYRE-Auto-23X5927

Global Musculoskeletal Disorders Therapeutics Market Insights, Forecast to 2028

FEATURED COMPANIES

Segment by Type

Segment by Application

BY COMPANY

BY REGION

FEATURED COMPANIES

FEATURED COMPANIES

HAVE A QUERY?

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-23Z18292

Thu Dec 12 00:00:00 UTC 2024

120 Pages

Type: Report

Code: QYRE-Auto-14Z15017

Thu Dec 12 00:00:00 UTC 2024

120 Pages

Type: Report

Code: QYRE-Auto-7M18883

Thu Dec 12 00:00:00 UTC 2024

120 Pages

Type: Report

Code: QYRE-Auto-37J14968

Thu Dec 12 00:00:00 UTC 2024

Support Contacts

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

POLICIES

THE COMPANY

CUSTOMER SUPPORT

OUR PRODUCTS

POLICES

Copyright © 2018 Valuates.com. All Rights Reserved.

Sitemap - Privacy Policy - Terms & Conditions